Lukáš Plank

Last updated • 2 min readFrom Wikipedia, The Free Encyclopedia

Lukáš Plank
Lukas Plank.jpg
Born1951
Nationality Slovak
Citizenship Slovakia
Alma materJessenius School of Medicine
Known for Molecular pathology
Hematopathology
Oncopathology
Scientific career
FieldsMedicine, pathology
Institutions Comenius University in Bratislava
Jessenius School of Medicine
Martin University Hospital

Lukáš Plank (born 1951) is a Slovak medical researcher, pathologist, and author.

Contents

Career

He studied medicine at, and is currently a professor of pathology at the Jessenius School of Medicine in Martin which is a part of the Comenius University in Bratislava. He was also the head of the department of Pathology at the Martin University Hospital. [1] He is the former chairman of the Slovak Scientific Council (Slovak : Vedecka Rada). [2]

He has written numerous journal articles, authored four textbooks for students and has a record number of citations in the literature. [3] [ failed verification ] He is considered a leading expert in the fields of oncopathology and hematopathology. [4] [ failed verification ] His research has made notable contributions regarding the current understanding of certain types of cancers.[ citation needed ] In November 2011 he was awarded the Mayors' Award by the city of Martin for achievements and significant results in scientific research and medicine. [5]

Selected publications

Bibliography

Related Research Articles

<span class="mw-page-title-main">Lymphoma</span> Hematologic cancer that affects lymphocytes

Lymphoma is a group of blood and lymph tumors that develop from lymphocytes. The name typically refers to just the cancerous versions rather than all such tumours. Signs and symptoms may include enlarged lymph nodes, fever, drenching sweats, unintended weight loss, itching, and constantly feeling tired. The enlarged lymph nodes are usually painless. The sweats are most common at night.

<span class="mw-page-title-main">Lymphatic system</span> Organ system in vertebrates complementary to the circulatory system

The lymphatic system, or lymphoid system, is an organ system in vertebrates that is part of the immune system and complementary to the circulatory system. It consists of a large network of lymphatic vessels, lymph nodes, lymphoid organs, lymphatic tissue and lymph. Lymph is a clear fluid carried by the lymphatic vessels back to the heart for re-circulation. The Latin word for lymph, lympha, refers to the deity of fresh water, "Lympha".

<span class="mw-page-title-main">Burkitt lymphoma</span> Cancer of the lymphatic system

Burkitt lymphoma is a cancer of the lymphatic system, particularly B lymphocytes found in the germinal center. It is named after Denis Parsons Burkitt, the Irish surgeon who first described the disease in 1958 while working in equatorial Africa. It is a highly aggressive form of cancer which often, but not always, manifests after a person develops acquired immunodeficiency from infection with Epstein-Barr Virus or Human Immunodeficiency Virus (HIV).

<span class="mw-page-title-main">Chronic lymphocytic leukemia</span> Bone marrow cancer in which lymphocytes are overproduced

Chronic lymphocytic leukemia (CLL) is a type of cancer in which the bone marrow makes too many lymphocytes. Early on, there are typically no symptoms. Later, non-painful lymph node swelling, feeling tired, fever, night sweats, or weight loss for no clear reason may occur. Enlargement of the spleen and low red blood cells (anemia) may also occur. It typically worsens gradually over years.

<span class="mw-page-title-main">Tumors of the hematopoietic and lymphoid tissues</span> Tumors that affect the blood, bone marrow, lymph, and lymphatic system

Tumors of the hematopoietic and lymphoid tissues or tumours of the haematopoietic and lymphoid tissues are tumors that affect the blood, bone marrow, lymph, and lymphatic system. Because these tissues are all intimately connected through both the circulatory system and the immune system, a disease affecting one will often affect the others as well, making aplasia, myeloproliferation and lymphoproliferation closely related and often overlapping problems. While uncommon in solid tumors, chromosomal translocations are a common cause of these diseases. This commonly leads to a different approach in diagnosis and treatment of hematological malignancies. Hematological malignancies are malignant neoplasms ("cancer"), and they are generally treated by specialists in hematology and/or oncology. In some centers "hematology/oncology" is a single subspecialty of internal medicine while in others they are considered separate divisions. Not all hematological disorders are malignant ("cancerous"); these other blood conditions may also be managed by a hematologist.

<span class="mw-page-title-main">Cutaneous T-cell lymphoma</span> Type of immune system cancer

Cutaneous T-cell lymphoma (CTCL) is a class of non-Hodgkin lymphoma, which is a type of cancer of the immune system. Unlike most non-Hodgkin lymphomas, CTCL is caused by a mutation of T cells. The cancerous T cells in the body initially migrate to the skin, causing various lesions to appear. These lesions change shape as the disease progresses, typically beginning as what appears to be a rash which can be very itchy and eventually forming plaques and tumors before spreading to other parts of the body.

<span class="mw-page-title-main">B-cell lymphoma</span> Blood cancer that affects B-type white blood cells

The B-cell lymphomas are types of lymphoma affecting B cells. Lymphomas are "blood cancers" in the lymph nodes. They develop more frequently in older adults and in immunocompromised individuals.

<span class="mw-page-title-main">Diffuse large B-cell lymphoma</span> Type of blood cancer

Diffuse large B-cell lymphoma (DLBCL) is a cancer of B cells, a type of lymphocyte that is responsible for producing antibodies. It is the most common form of non-Hodgkin lymphoma among adults, with an annual incidence of 7–8 cases per 100,000 people per year in the US and UK. This cancer occurs primarily in older individuals, with a median age of diagnosis at ~70 years, although it can occur in young adults and, in rare cases, children. DLBCL can arise in virtually any part of the body and, depending on various factors, is often a very aggressive malignancy. The first sign of this illness is typically the observation of a rapidly growing mass or tissue infiltration that is sometimes associated with systemic B symptoms, e.g. fever, weight loss, and night sweats.

<span class="mw-page-title-main">Neprilysin</span> Mammalian protein found in Homo sapiens

Neprilysin is an enzyme that in humans is encoded by the MME gene. Neprilysin is a zinc-dependent metalloprotease that cleaves peptides at the amino side of hydrophobic residues and inactivates several peptide hormones including glucagon, enkephalins, substance P, neurotensin, oxytocin, and bradykinin. It also degrades the amyloid beta peptide whose abnormal folding and aggregation in neural tissue has been implicated as a cause of Alzheimer's disease. Synthesized as a membrane-bound protein, the neprilysin ectodomain is released into the extracellular domain after it has been transported from the Golgi apparatus to the cell surface.

<span class="mw-page-title-main">Aggressive NK-cell leukemia</span> Medical condition

Aggressive NK-cell leukemia is a disease with an aggressive, systemic proliferation of natural killer cells and a rapidly declining clinical course.

<span class="mw-page-title-main">Peripheral T-cell lymphoma not otherwise specified</span> Medical condition

Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), is a subtype of peripheral T-cell lymphoma. Peripheral T-cell lymphoma (PTCL) is defined as a diverse group of aggressive lymphomas that develop from mature-stage white blood cells called T-cells and natural killer cells. PTCL is a type of non-Hodgkin's lymphoma (NHL). PTCL specifically affects T-cells rather than B-cells, and results when T-cells develop and grow abnormally.

For the Irish playwright and screenwriter, see Nancy Harris.

<span class="mw-page-title-main">Karl Lennert</span> German physician and pathologist (1921–2012)

Karl Lennert, M.D. was a German physician and pathologist.

Thomas Grogan is an American professor, pathologist and founder of Ventana Medical Systems, Inc. He currently holds the positions of Professor of Pathology at the University of Arizona College of Medicine and Chief Scientific Officer at Ventana.

Jan Jakuš is a Slovak medical researcher, author and professor of Pathophysiology.

<span class="mw-page-title-main">Elaine Jaffe</span> American pathologist

Elaine Sarkin Jaffe is a senior National Cancer Institute (NCI) investigator at the National Institutes of Health (NIH) most well known for her contribution to hematopathology. She completed her medical education at Cornell University and the University of Pennsylvania, receiving her M.D. degree from University of Pennsylvania in 1969. After an internship at Georgetown University she joined NCI as a resident in anatomic pathology, and has been a senior investigator since 1974, focusing on the classification and definition of lymphomas. Jaffe's early work helped to provide a deeper understanding of the origin of lymphomas, especially follicular lymphoma. Her team notably elucidated the difference between T cell and B cell lymphomas.

Günter Burg is a German dermatologist. Born in Mayen, Germany, he holds German and Swiss citizenship. He has been married to Dr. Doris Burg-Nicklas, a neurologist, since 1968. They have two sons: Andreas and Thomas.

Dennis Howard Wright was a British medical doctor and professor of pathology with an international reputation in haematopathology.

References

  1. Zárecký, Ľudovít (2008). "Patológia a súdne lekárstvo" (in Slovak). Farmako Ekonomika. Archived from the original on 4 March 2016.
  2. Petkova, Zuzana (21 January 2006). "Na výskum dá zajac viac peniazí" (PDF). Pravda (in Slovak). Retrieved 23 September 2012.[ permanent dead link ]
  3. Plus 7, Days (2010). "The main expert of the Ministry of Health Department of Pathology prof. MD. Lukas Plank, MD. (59)". Doctors (in Slovak). Pluska.sk. Retrieved 26 July 2012.{{cite web}}: CS1 maint: numeric names: authors list (link)
  4. Slovakova, Alzbeta (February 2008). "Patolog, Lekar ktory nelieci" (in Slovak). smer.sk. Retrieved 26 July 2012.
  5. Legerska, Viera (12 November 2011). "Were added to the gallery of exceptional new names". turiec.sme.sk (in Slovak). Retrieved 23 September 2012.